AstraZeneca reveals insurance fraud probe in China as offici

China’s healthcare fund watchdog is taking AstraZeneca to task over alleged fraud. AstraZeneca China last month met with government officials as part of an investigation into alleged insurance fraud, the company said Friday. The probe—and subsequent arrests—hinge on suspicions that AZ China staff members tampered with genetic testing results of cancer patients in order to defraud medical insurance funds.

Related Keywords

Shenzhen , Guangdong , China , Chinese , , Glaxosmithkline , Astrazeneca , Ministry Of Public Security , National Healthcare Security Administration , Xinhua , Reuters , Zeneca China , Astrazeneca China , Public Security , Fraud , Medical Insurance , Criminal Case , Arketing Investigation , Pharma ,